VeriMomlavandula angustifolia flower oil hamilelikte güvenli mi?
No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
Hamilelikte lavandula angustifolia flower oil yerine kullanılabilecek güvenli alternatifler | VeriMom
Related ingredients
Frequently asked questions
- lavandula angustifolia flower oil hamilelikte güvenli mi?
- No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
- lavandula angustifolia flower oil emzirirken güvenli mi?
- Same rationale as pregnancy: no harmonised classification or regulatory ban; mechanistic/in vitro signals exist but in vivo data do not confirm estrogenicity. Systemic absorption from topical use is low, so maternal exposure and transfer into breastmilk are possible but expected to be low from normal cosmetic use; therefore h=1, m=2, e=1.
- lavandula angustifolia flower oil bebek cildi için güvenli mi?
- Hazard remains low/theoretical (h=1) because human case reports/in vitro activity exist but no harmonised classification or conclusive animal reproductive/teratogenic evidence. Mechanistic signals (estrogenic/anti‑androgenic activity in vitro) are documented (m=2). Exposure score is increased by +1 for infants (immature skin barrier, higher surface-to-weight ratio) giving e=2 for baby topical exposure. Additionally, lavender oil constituents (oxidized linalool) are recognised contact allergens—relevance for infant skin sensitization is separate from reproductive scoring.
- VeriMom lavandula angustifolia flower oil nasıl puanlıyor?
- VeriMom lavandula angustifolia flower oil'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 60/100 (orta risk) olarak puanlar.
- Hamilelikte lavandula angustifolia flower oil yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.